Question 1

What is Ligand Pharmaceuticals's deferred tax assets and other non-current assets?

Accepted Answer

Ligand Pharmaceuticals (LGND) reported deferred tax assets and other non-current assets of $11.84M in Q2 2026.

Question 2

How has Ligand Pharmaceuticals's deferred tax assets and other non-current assets changed year-over-year?

Accepted Answer

Ligand Pharmaceuticals's deferred tax assets and other non-current assets increased by 30.0% year-over-year, from $9.11M to $11.84M.

Question 3

What is the long-term trend for Ligand Pharmaceuticals's deferred tax assets and other non-current assets?

Accepted Answer

Over 5 years (2020 to 2025), Ligand Pharmaceuticals's deferred tax assets and other non-current assets has grown at a 24.1% compound annual growth rate (CAGR), from $4.27M to $12.58M.

Question 4

What does deferred tax assets and other non-current assets mean?

Accepted Answer

Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

Line item	June 30, 2026	December 31, 2025
Equity method investments	42,390	46,500
Other investments	114,483	121,451
Deferred income taxes, net	37,119	8,345
Other assets	11,841	12,582
Total assets	$2,185,875	$1,560,637
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$9,405	$3,238

Deferred Tax Assets and Other Non-Current Assets at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Ligand Pharmaceuticals's deferred tax assets and other non-current assets.

Ligand Pharmaceuticals LGND Deferred Tax Assets and Other Non-Current Assets